Literature DB >> 19179477

Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.

Barbara Guinn, Jochen Greiner, Michael Schmitt, Ken I Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19179477     DOI： 10.1182/blood-2008-09-178848

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Molecular Mechanisms and Therapies of Myeloid Leukaemia.

Authors:  Elliott Brown; Barbara-Ann Guinn
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

2.  Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.

Authors:  Pu Li; Xuehua Chen; Liping Su; Chenglong Li; Qiaoming Zhi; Beiqin Yu; Hong Sheng; Junqing Wang; Runhua Feng; Qu Cai; Jianfang Li; Yingyan Yu; Min Yan; Bingya Liu; Zhenggang Zhu
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

3.  A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.

Authors:  Xun Liu; Bobo Chen; Jiahui Chen; Shaolong Sun
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

4.  MiRNA-181b-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis by Targeting SSX2IP in Acute Lymphoblastic Leukemia

Authors:  Xue Fu; Yuan He; Jun Song; Linhui Wang; Pengxiang Guo; Jun Cao
Journal:  Turk J Haematol       Date:  2022-06-06       Impact factor: 2.029

5.  CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.

Authors:  Mingdi Zhang; Kejin Wu; Maoli Wang; Fang Bai; Hongliang Chen
Journal:  Int J Anal Chem       Date:  2022-09-25       Impact factor: 1.698

6.  SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma.

Authors:  Pu Li; Ying Lin; Yu Zhang; Zhenggang Zhu; Keke Huo
Journal:  J Transl Med       Date:  2013-03-01       Impact factor: 5.531

7.  Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

Authors:  Suzanne E Brooks; Stephanie A Bonney; Cindy Lee; Amy Publicover; Ghazala Khan; Evelien L Smits; Dagmar Sigurdardottir; Matthew Arno; Demin Li; Ken I Mills; Karen Pulford; Alison H Banham; Viggo van Tendeloo; Ghulam J Mufti; Hans-Georg Rammensee; Tim J Elliott; Kim H Orchard; Barbara-ann Guinn
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

Review 8.  New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.

Authors:  Stephanie Jordaens; Leah Cooksey; Laurie Freire Boullosa; Viggo Van Tendeloo; Evelien Smits; Ken I Mills; Kim H Orchard; Barbara-Ann Guinn
Journal:  Cancer Immunol Immunother       Date:  2020-01-22       Impact factor: 6.968

Review 9.  Increasing Role of Targeted Immunotherapies in the Treatment of AML.

Authors:  Jochen Greiner; Marlies Götz; Verena Wais
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.